Top

European Child & Adolescent Psychiatry

Published in:

01-06-2007 | ORIGINAL CONTRIBUTION

Prevalence of use, abuse and dependence on legal and illegal psychotropic substances in an adolescent inpatient psychiatric population

Authors: Dr. Oliver Niethammer, Prof. Dr. Reiner Frank

Published in: European Child & Adolescent Psychiatry | Issue 4/2007

Abstract

Objective

To examine the prevalence of use, abuse, and dependence on legal and illegal psychotropic substances in an adolescent in-patient psychiatric population in relation to age and gender.

Methods

Participants were all consecutive admissions (patients aged from 14 to 17) to the adolescent psychiatric in-patient unit. Of the 86 patients who met all the criteria for taking part in the study 70 were interviewed, giving a response rate of 81%. Prevalence of use and of substance use disorders were assessed through structured diagnostic interviews (M-CIDI), conducted from March 2000 through July 2000.

Results

We found high prevalence of use and of the diagnosis of legal and illegal psychotropic substances. Around 76% reported a regular use of tobacco, 44% regular alcohol use, and 40% regular use of illegal substances. Diagnosis (abuse or dependence) was found in 50% of cases for nicotine, 29% for alcohol, and 26% for illegal substances.

Conclusions

The adolescent in-patient psychiatric population is at high risk of use, abuse, and dependence on legal and illegal psychotropic substances. It is important to diagnose these disorders (anamnesis, screening tools) and to install preventive and therapeutic programs in clinical therapeutic settings.

Bundeszentrale für gesundheitliche Aufklärung (Federal Centre for Health Education) (1994, 1997, 2001, 2004). Die Drogenaffinität Jugendlicher in der BRD

Chen K, Kandel DB (1995) The natural history of drug use from adolescence to the mid-thirties in a general population sample. Am J Public Health 85:41–47PubMedCrossRef

Deas-Nesmith D, Campbell S, Brady KT (1998) Substance use disorders in an adolescent inpatient psychiatric population. J Natl Med Assoc 90:233–238PubMed

Fulkerson JA, Harrison PA, Beebe TJ (1999) DSM-IV substance abuse and dependence: are there really two dimensions of substance use disorders in adolescents? Addiction 94:495–506PubMedCrossRef

Hansen SS, Munk-Jorgensen P, Guldbaek B, Solgard T, Lauszus KS, Albrechtsen N, Borg L, Egander A, Faurholdt K, Gilberg A, Godsen NP, Lorenzen J, Richelsen B, Weischer K, Bertelsen A (2000) Psychoactive substance use diagnoses among psychiatric in-patients. Acta Psychiatr Scand 102:432–438PubMedCrossRef

Kandel DB, Johnson JG, Bird H, Weissman MM, Goodman SH, Lahey BB, Regier DA, Schwab-Stone ME (1999) Psychiatric comorbidity among adolescents with substance use disorders: findings from the MECA study. J Am Acad Child Adolesc Psychiatry 38:693–699PubMedCrossRef

Kandel DB, Yamaguchi K, Chen K (1992) Stages of progression in drug involvment from adolescence to adulthood: further evidence for the gateway theory. J Stud Alcohol 53:447–457PubMed

Kessler RC, McGonagle KA, Zhao S, Nelson C, Hughes M, Eshleman S, Wittchen H-U, Kendler KS (1994) Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry 51:8–19PubMed

Lachner G, Wittchen H-U, Perkonigg A, Holly A, Schuster P, Wunderlich U, Türk D, Garczynski E, Pfister H (1998) Structure, content and reliability of the Munich-Composite International Diagnostic Interview (M-CIDI). Substance use sections. Eur Addict Res 4:28–41PubMedCrossRef

10.

Lieb R, Schuster P, Pfister H, Fuetsch M, Höfler M, Isensee B, Müller N, Sonntag H, Wittchen H-U (2000) Epidemiologie des Konsums, Missbrauch und der Abhängigkeit von legalen und illegalen Drogen bei Jugendlichen und jungen Erwachsenen: die prospektiv-longitudinale Verlaufstudie EDSP. Sucht 46:18–31

11.

Nelson CB, Wittchen H-U (1998) DSM-IV alcohol disorders in a general population sample of adolescents and young adults. Addiction 93:1065–1077PubMedCrossRef

12.

Nelson CB, Wittchen H-U (1998) The EDSP: setting the stage! Eur Addict Res 4:5–7PubMedCrossRef

13.

Nelson CB, Wittchen H-U (1998) Smoking and nicotine dependence. Eur Addict Res 4:42–49PubMedCrossRef

14.

Perkonigg A, Lieb R, Wittchen H-U (1998) Substance use, abuse and dependence in Germany. A review of selected epidemiological data. Eur Addict Res 4:8–17PubMedCrossRef

15.

Perkonigg A, Lieb R, Wittchen H-U (1998) Prevalence of use, abuse and dependence of illicit drugs among adolescents and young adults in a community sample. Eur Addict Res 4:58–66PubMedCrossRef

16.

Reed V, Gander F, Pfister H, Steiger A, Sonntag H, Trenkwalder C, Sonntag A, Hundt W, Wittchen H-U (1998) To what degree does the Composite International Diagnostic Interview (CIDI) correctly identifies DSM-IV disorders? Testing validity issues in a clinical sample. Int J Methods Psychiatr Res 7:142–155CrossRef

17.

Warner LA, Kessler RC, Hughes M, Anthony J, Nelson C (1995) Prevalence and correlates of drug use and dependence in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry 52:219–229PubMed

18.

Wittchen H-U et al. (1998) Test–retest reliability of the computerized DSM-IV version of the Munich Composite International Diagnostic Interview (M-CIDI). Soc Psychiatry Psychiatr Epidemiol 33:568–578PubMedCrossRef

19.

Wittchen H-U (1994) Reliability and validity studies of the WHO-Composite International Diagnostic Interview (CIDI): a critical review. J Psychiatr Res 28:57–84PubMedCrossRef

Title: Prevalence of use, abuse and dependence on legal and illegal psychotropic substances in an adolescent inpatient psychiatric population
Authors: Dr. Oliver Niethammer
Prof. Dr. Reiner Frank
Publication date: 01-06-2007
Publisher: D. Steinkopff-Verlag
Published in: European Child & Adolescent Psychiatry / Issue 4/2007
Print ISSN: 1018-8827
Electronic ISSN: 1435-165X
DOI: https://doi.org/10.1007/s00787-006-0597-5

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Prevalence of use, abuse and dependence on legal and illegal psychotropic substances in an adolescent inpatient psychiatric population

Abstract

Objective

Methods

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Objective

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 4/2007

Remitting brief psychotic disorder in a 15-year-old male

The EU-regulation on medicinal products for paediatric use

Pathways of behavioural and emotional symptoms in kindergarten children: What is the role of pro-social behaviour?

Problem behavior in a community sample of 14- and 19-month-old children

Consequences of prenatal toxin exposure for mental health in children and adolescents

Transparent criteria for specialist level adolescent psychiatric care